Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clene (CLNN) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Clene (CLNN) over the last 6 years, with Q3 2025 value amounting to $22.3 million.

  • Clene's Liabilities and Shareholders Equity fell 2932.62% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.1 million, marking a year-over-year decrease of 4265.69%. This contributed to the annual value of $27.3 million for FY2024, which is 4777.13% down from last year.
  • Per Clene's latest filing, its Liabilities and Shareholders Equity stood at $22.3 million for Q3 2025, which was down 2932.62% from $22.1 million recorded in Q2 2025.
  • In the past 5 years, Clene's Liabilities and Shareholders Equity registered a high of $73.3 million during Q2 2021, and its lowest value of $22.1 million during Q2 2025.
  • Its 5-year average for Liabilities and Shareholders Equity is $46.4 million, with a median of $44.5 million in 2022.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first crashed by 5070.44% in 2022, then soared by 6785.08% in 2023.
  • Clene's Liabilities and Shareholders Equity (Quarter) stood at $63.1 million in 2021, then fell by 29.45% to $44.5 million in 2022, then grew by 17.64% to $52.3 million in 2023, then tumbled by 47.77% to $27.3 million in 2024, then decreased by 18.39% to $22.3 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $22.3 million for Q3 2025, versus $22.1 million for Q2 2025 and $25.3 million for Q1 2025.